A new treatment for prostate cancer developed and trialled in London has been licensed for use.
Enzalutamide was developed by researchers at the Royal Marsden and University College London hospitals.
The one a day pill checks the spread of the cancer.
Reseachers say the most exciting aspect of this new drug is that is has very few side effects- unlike many cancer treatements.
More top news
A cyclist who ploughed into a mother-of-two has been cleared of manslaughter but convicted of "wanton and furious driving".
Women in Tower Hamlets can expect to live for 30 years in ill health, compared to just under 12 years for men in Enfield.
Travel website Lonely Planet has included Tooting, south London, in its list of the globe's must-visit locations.